Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:01 AM
Ignite Modification Date:
2025-12-25 @ 1:01 AM
NCT ID:
NCT06448793
Eligibility Criteria:
Inclusion Criteria:
Patients
* Aged ≥18 years at the time of enrollment in the study
* Resident of the US, Germany, or Japan
* Able to read, speak, and understand English, German or Japanese
* Diagnosed with resectable phase II to IIIB non-small cell lung cancer (NSCLC)
Physicians
* Resident of the US, Germany, or Japan
* Lung cancer-treating physician specialized in one of the following medical areas: oncology, pneumonology, thoracic surgery, or radiology
* Treated at least three new patients with resectable NSCLC in the past year
Exclusion Criteria:
Patients
* Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment)
* Being diagnosed with another malignancy alongside NSCLC
* Not willing to be audio-recorded during the interview
Physicians
* Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment)
* Not willing to be audio-recorded during the interview
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06448793
Study Brief:
Protocol Section:
NCT06448793